HALL CAPITAL MANAGEMENT CO INC

Position in LLY — ELI LILLY & Co

CIK 1122490 BARRINGTON, RI

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,104,125

+$1,961,771 QoQ

Shares Held

2,588

+108.4% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.56%

of 13F equity value

Holder Rank

#2,093

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

HALL CAPITAL MANAGEMENT CO INC holds $16,204,286 across 6 Drug Manufacturers - General names. LLY ranks #3 (19.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	27,021	$6,862,523
2	ABBV	AbbVie Inc.	15,560	$3,915,518
3	LLY	ELI LILLY & Co This page	2,588	$3,104,125
4	BMY	Bristol Myers Squibb Co	25,573	$1,473,516
5	MRK	Merck & Co., Inc.	4,183	$537,515
6	NVS	Novartis AG	1,985	$311,089

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,104,125	2,588	+108.4%	Shares	Sole	2026-08-14
2026-03-31	$1,142,354	1,242	+469.7%	Shares	Sole	2026-05-11
2025-12-31	$234,280	218	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.